PS Ratio
-1.39
-0.03-2.21%
Sat, 15 Feb 2025 00:46:13 GMT
Summary
- As of February 18, 2025, CTCX price to sales ratio is -1.39, with a fall of -0.03 (-2.21%) during the most recent trading day.
- CTCX PS ratio is now -100.04% below its all-time high of 3110.32.
Performance
CTCX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CTCX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -2.2% | +2.1% | +2.1% | -10000.0% |
| 1 m1 month | +57.8% | -57.9% | -57.9% | - |
| 3 m3 months | -1.5% | +1.2% | +1.2% | 0.0% |
| 6 m6 months | -100.1% | -73.4% | -73.4% | - |
| ytdytd | +12.0% | -12.5% | -12.5% | - |
| 1 y1 year | - | -93.5% | -94.1% | 0.0% |
| 5 y5 years | - | - | - | - |
CTCX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.2% | -3.29 | +57.8% | |
| 3 m | 3-month | -1.19 | -16.8% | -3.54 | +60.7% |
| 6 m | 6-month | 1716.62 | -100.1% | -3.85 | +63.9% |
| 1 y | 1-year | 3110.32 | -100.0% | -3.85 | +63.9% |
| 3 y | 3-year | 3110.32 | -100.0% | -3.85 | +63.9% |
| 5 y | 5-year | 3110.32 | -100.0% | -3.85 | +63.9% |
| alltime | all time | 3110.32 | -100.0% | -3.85 | +63.9% |
Carmell Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | -1.39(-12.0%) |
| Date | Value |
|---|---|
| 2024 | -1.58 |
FAQ
- What is Carmell Therapeutics price to sales ratio?
- What is the all time high PS ratio for Carmell Therapeutics?
- What is CTCX price to sales ratio year-to-date change?
What is Carmell Therapeutics price to sales ratio?
The current PS ratio of CTCX is -1.39
What is the all time high PS ratio for Carmell Therapeutics?
Carmell Therapeutics all-time high price to sales ratio is 3110.32
What is CTCX price to sales ratio year-to-date change?
Carmell Therapeutics price to sales ratio has changed by +0.19 (+12.03%) since the beginning of the year